View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Neuroendocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 02, 2023
8 min watch
Save

VIDEO: Pituitary and adrenal research highlights from ECE 23

VIDEO: Pituitary and adrenal research highlights from ECE 23

In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary and adrenal research highlights presented at ECE 2023, the annual meeting of the European Society of Endocrinology, which took place in Istanbul, Turkey, in May.

SPONSORED CONTENT
May 15, 2023
5 min read
Save

Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome

Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome

To achieve optimal outcomes in Cushing’s syndrome, both clinicians and patients need to be prepared for the type and duration of symptoms that patients may experience during treatment and recovery.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
February 28, 2023
2 min read
Save

Most pituitary microadenomas do not change in size over 5 years of follow-up

Most pituitary microadenomas do not change in size over 5 years of follow-up

Most adults with incident pituitary microadenomas have no change in size or a decrease in size during a median follow-up of nearly 5 years, according to findings published in Annals of Internal Medicine.

SPONSORED CONTENT
January 26, 2023
1 min read
Save

FDA approves spinal cord stimulation system for diabetic pain

FDA approves spinal cord stimulation system for diabetic pain

The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, manufacturer Abbott announced in a press release.

SPONSORED CONTENT
November 07, 2022
3 min read
Save

Cushing’s syndrome treatment maintains reductions in urinary free cortisol for 12 months

Cushing’s syndrome treatment maintains reductions in urinary free cortisol for 12 months

Most adults with Cushing’s syndrome receiving levoketoconazole twice daily maintained reductions in mean urinary free cortisol levels during a 12-month maintenance period, according to findings from the SONICS study extended evaluation.

SPONSORED CONTENT
October 12, 2022
1 min read
Save

Presence of type 2 diabetes in acromegaly increases mortality and morbidity risks

Presence of type 2 diabetes in acromegaly increases mortality and morbidity risks

Among adults with acromegaly, concomitant type 2 diabetes was associated with increased risks for overall mortality and for cardiovascular mortality and morbidity, researchers reported in The Journal of Clinical Endocrinology & Metabolism.

SPONSORED CONTENT
September 15, 2022
2 min read
Save

Osilodrostat normalizes urinary free cortisol in Cushing’s disease for most at 72 weeks

Osilodrostat normalizes urinary free cortisol in Cushing’s disease for most at 72 weeks

More than 80% of adults with Cushing’s disease receiving osilodrostat had normalized mean urinary free cortisol levels at 72 weeks of treatment, according to findings from the LINC 3 study extension.

SPONSORED CONTENT
September 09, 2022
2 min read
Save

Endoscopic surgery confers higher acromegaly remission rate than microscopic surgery

Endoscopic surgery confers higher acromegaly remission rate than microscopic surgery

Endoscopic transsphenoidal surgery has the best remission rates and fewest postoperative complications for adults with acromegaly, according to findings from a systematic review.

SPONSORED CONTENT
July 25, 2022
1 min read
Save

More than 15% of patients at risk for rare cancers missed screenings during COVID

More than 15% of patients at risk for rare cancers missed screenings during COVID

CHICAGO — In rare hereditary cancers such as paraganglioma/pheochromocytoma, where patients travel for their care, COVID caused a disruption in their screening and treatments, according to a poster presented during ASCO Annual Meeting.

SPONSORED CONTENT
June 27, 2022
2 min read
Save

Sleep deprivation may prevent counterregulatory adaptation to recurrent hypoglycemia

Sleep deprivation may prevent counterregulatory adaptation to recurrent hypoglycemia

In a cohort of healthy young adult men, one night of sleep deprivation attenuated the adaptation to recurrent hypoglycemia by preserving neuroendocrine counterregulation and subjective awareness, according to study findings.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails